pLV-TetO-hNGN2-Puro Citations (4)
Originally described in: Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells.Ho SM, Hartley BJ, Tcw J, Beaumont M, Stafford K, Slesinger PA, Brennand KJ Methods. 2015 Nov 25. pii: S1046-2023(15)30159-6. doi: 10.1016/j.ymeth.2015.11.019. PubMed Journal
Articles Citing pLV-TetO-hNGN2-Puro
| Articles |
|---|
Cell Type-Specific In Vitro Gene Expression Profiling of Stem Cell-Derived Neural Models.
Gregory JA, Hoelzli E, Abdelaal R, Braine C, Cuevas M, Halpern M, Barretto N, Schrode N, Akbalik G, Kang K, Cheng E, Bowles K, Lotz S, Goderie S, Karch CM, Temple S, Goate A, Brennand KJ, Phatnani H.
Cells. 2020 Jun 5;9(6). pii: cells9061406. doi: 10.3390/cells9061406.
PubMed
Associated Plasmids |
| Efficient Derivation of Excitatory and Inhibitory Neurons from Human Pluripotent Stem Cells Stably Expressing Direct Reprogramming Factors. Song S, Ashok A, Williams D, Kaufman M, Duff K, Sproul A. Curr Protoc. 2021 Jun;1(6):e141. doi: 10.1002/cpz1.141. PubMed |
| SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS. Linares GR, Li Y, Chang WH, Rubin-Sigler J, Mendonca S, Hong S, Eoh Y, Guo W, Huang YH, Chang J, Tu S, Dorjsuren N, Santana M, Hung ST, Yu J, Perez J, Chickering M, Cheng TY, Huang CC, Lee SJ, Deng HJ, Bach KT, Gray K, Subramanyam V, Rosenfeld J, Alworth SV, Goodarzi H, Ichida JK. Cell Stem Cell. 2023 Feb 2;30(2):171-187.e14. doi: 10.1016/j.stem.2023.01.005. PubMed |
| Precise Therapeutic Targeting of Distinct NRXN1(+/-) Mutations. Fernando MB, Fan Y, Zhang Y, Kammourh S, Murphy AN, Ghorbani S, Onatzevitch R, Pero A, Padilla C, Flaherty EK, Prytkova IK, Cao L, Williams S, Fang G, Slesinger PA, Brennand KJ. bioRxiv [Preprint]. 2023 Dec 23:2023.10.28.564543. doi: 10.1101/2023.10.28.564543. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.